In this episode of Life Science Talent Talks, host Nehar Mortuza sits down with Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk. Rahmad shares his remarkable journey from his roots in Indonesia to his pivotal role at the forefront of machine learning-driven protein engineering. Together, they explore how AI is revolutionising antibody design — from the technical advances and current challenges to the growing role of generative models in creating next-generation therapeutics. Rahmad offers insights into how these technologies are accelerating drug discovery, improving patient outcomes, and shaping the future of healthcare. He also speaks candidly about his transition from academia to industry, the personal motivations that fuel his work, and why collaboration and innovation are more essential than ever in the life sciences. Whether you're passionate about biotech, data science, or career development, this episode is packed with valuable perspectives you won't want to miss.

Timestamp and Show notes:

00:38 Meet Our Special Guest: Rahmad Akbar

02:19 Rahmad's Journey: From Indonesia to Novo Nordisk

03:35 The Role of Coding in Biotechnology

04:45 Antibody Design: Challenges and Innovations

06:48 Generative AI in Drug Design

10:04 Future Trends and Democratizing AI

19:00 Personal Motivations and Career Reflections

24:31 Transitioning from Academia to Industry

29:47 Final Thoughts and Takeaways

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we take you inside the story of Mmimetika, a biotech venture co-founded by researchers Mogens Johannsen and Thomas Poulsen. What began as a bold university lab project has grown into a breakthrough company developing a compound that mimics some of the key health benefits of exercise and fasting.

By combining ketones and lactate in a single, novel molecule, Mmimetika's lactate | ketone non-medicinal supplement provides promising support for metabolic control and longevity.

We dive into their journey from academic discovery to commercial reality — securing patents, scaling production, attracting investors, and building a business team around their scientific vision.

Now on the cusp of regulatory approval, Mmimetika is actively searching for a dynamic CEO to lead the charge into market launch and long-term growth.

Whether you're curious about biotech entrepreneurship, metabolic health innovations, or how groundbreaking research turns into real-world solutions, this is a story you won’t want to miss.

Shownotes and Timestamps

[00:00:00] Company Introduction  

[00:01:12] Mimicking Exercise and Fasting  

[00:04:08] Current Status and Journey  

[00:05:54] Product Superiority and Development  

[00:08:13] Competition and IP  

[00:10:18] Funding and Investor Relations  

[00:11:17] Technical Aspects of the Product  

[00:13:00] Clinical Evidence and Scientific Approach  

[00:14:22] Non-Medical Claims

[00:15:29] Market Focus and Positioning  

[00:17:58] Roadmap and Milestones  

[00:21:22] Organizational Structure and Key Risks  

[00:23:00] CEO Transition and Future Roles  

[00:25:04] Company Culture and CEO Profile  

[00:27:26] Soft Skills and Ideal Timing for CEO  

[00:29:42] How Listeners Can Support  

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we sit down with Janine Erler, CEO, and Lluís Riera Ponsati, Program Lead at NEUmiRNA Therapeutics to discuss their groundbreaking work in developing disease-modifying RNA therapies for neurological disorders.

From their startup journey to the intricate science behind their therapies, the conversation spans key milestones, technology challenges, and the unique patient-focused culture at Neumirna.

Janine and Lluís share insights on their successful fundraising, the impact of their microRNA-based approach, and the practical aspects of going from academic research to clinical applications.

They also discuss the organizational dynamics, collaborations, and future aspirations of the company, making this a compelling listen for any life sciences professional interested in the transformative potential of RNA therapies.

Show notes & Timestamp

00:43 Introducing Neumirna Therapeutics

02:10 Founding Story of Neumirna

03:29 Key Milestones and Team Growth

06:50 Challenges and Collaborations

15:23 Technology Behind Neumirna's RNA Therapies

23:19 Focus on Neurological Diseases

24:57 Exploring the Potential of ASO Technology

25:26 The Future of RNA Therapies

27:44 Navigating Regulatory Challenges

28:37 Team and Culture at Neumirna

35:23 Hiring and Onboarding at Neumirna

37:36 Proud Moments and Achievements

43:02 Immediate Priorities and Challenges

44:43 Connecting with the Community

45:51 Conclusion and Final Thoughts

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Susanne Gløersen, founder of The Future of Fungi Award and Fungi Investment Collective, discusses her mission to build a global ecosystem fueled by fungi innovation. 

The conversation covers the multifaceted applications of fungi, from food and materials to packaging and environmental remediation.

Susanne shares the origins of her passion for fungi, the purpose and success of the Future Fungi Award, and the criteria for selecting award winners and investment opportunities. She emphasizes the role of fungi in addressing pressing environmental issues and the importance of collaboration and community in advancing fungi innovation. 

Additionally, Susanne dives into the workings of the Fungi Investment Collective, highlighting how it supports pioneering scientists and startups with funding and resources. 

Essential for anyone interested in sustainable innovation, this episode unveils the transformative potential of fungi and how it can drive us towards a more balanced and nature-cooperative economy.

Shownotes and Timestamps

00:55 Introduction and Overview of Fungi Innovation

01:55 Susanne's Background and Journey into Fungi

04:48 Mission and Vision for Fungi Innovation

06:38 The Future Fungi Award

08:07 Highlighting Award Winners and Their Innovations

15:06 Support and Collaboration Opportunities

19:22 Introduction to the Fungi Investment Collective

24:46 Building a Network of Science Venture Partners

25:30 Investment Priorities and Criteria

26:54 Funding Ranges and Case Dependency

27:54 Connecting with the Fungi Investment Collective

28:55 Opportunities for Aspiring Venture Partners

32:33 Proud Accomplishments and Network Effects

36:27 Challenges and Learnings as a First-Time Entrepreneur

41:12 Future of Fungi Innovation and Exciting Startups

46:33 Conclusion and Call to Join the Movement

Resources Mentioned:

Awards, Collectives, and Initiatives

- Fungi Investment Collective

- Venture Builder Pilot Program (for top scientists)

- The Mycelium Network (community concept)

Podcasts & Media

- The Future is Fungi Podcast

Notable Startups & Projects

- Jens Laurids Sørensen (battery out of fungi)

- Nova Biome (textile waste to bioactive compounds for cosmetics, in L'Oreal's accelerator)

- Line Kloster Pedersen, Visibuilt (Danish startup making mycelium binder for asphalt production)

- William Newell, Electromicrobial CO2 fixation project (Imperial College of London)

- Nomy (Norwegian Mycelium, feed for aquaculture)

- Michael Lever (German company, surfactants from fungi)

Conferences & Events

- ChangeNow (largest accessibility conference)

- IMC12 (International Mycology Congress)

- Brilliant Minds (an event where Obama and Malala have spoken)

Corporates & Partners

- L'Oreal (accelerator)

- Novo Holdings (jury pre-screening)

- SEB (Green Tech VC, large Nordic Bank)

Book Recommendations

-Entangled Life by Merlin Sheldrake

Other

- LinkedIn (The Fungi Investment Collective)

- Fungi Investment Collective website/contact form

- Email: [email protected]

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠

Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Nehar Mortuza looks into the dynamic world of life sciences with special guest Mikkel Skovborg, Vice President at the Novo Nordisk Foundation. Mikkel shares his journey from academia to industry and discusses the foundation’s mission to foster innovation, entrepreneurship, and scientific research. He highlights key initiatives like the Bio Innovation Institute (BII) and public-private partnerships that aim to enhance the life science ecosystem in Denmark and beyond. The conversation covers the impact of regulatory challenges, the promise of emerging technologies such as quantum computing and gene cell therapy, and the importance of global talent and collaborations. Mikkel also provides insights on the evolving landscape of life sciences, offering advice to aspiring professionals and reflecting on the lessons learned throughout his career.

Timestamps:

00:45 | Introducing Our Guest – Mikkel Skovborg

01:36 | Career Journey & Influences – From Academia to Industry

04:15 | The Mission & Impact of the Novo Nordisk Foundation

07:22 | Challenges & Opportunities in the Life Science Sector

14:03 | Denmark’s Role as a Hub for Startups & Talent

16:19 | Personal Insights & Reflections from Mikkel Skovborg

19:20 | Conclusion & Key Takeaways

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Guests: Susanne Palsten Buchardt (Incoming CEO) & Henrik Busch‑Larsen (Founder, former CEO at Algiecel)

Episode in a Tweet

When a founder steps aside, how do you keep the vision alive? Hear how Algiecel is turning a CEO hand‑over into rocket fuel for growth — while scaling microalgae tech that captures CO₂ and feeds the world.

What You’ll Learn

• How Algiecel’s photo‑bioreactor technology converts industrial CO₂ into high‑value microalgae ingredients.

• The behind‑the‑scenes playbook for planning a smooth CEO succession.

• Why trust, transparent communication, and role clarity made the hand‑over a win‑win.

• Susanne’s journey from strategy consultant to CCO to CEO—and Henrik’s new focus on partnerships & investment.

• Actionable advice for founders preparing their own succession road‑map.

00:00 Intro – Welcome & episode set‑up

02:04 Algiecel’s Mission & Tech – Microalgae, CO₂ utilisation, and photo‑bioreactors

04:45 Origin Story – Henrik’s eco‑vision and the company’s early pivots

09:08 Why Succession & Why Now? – Spotting the right moment for change

12:56 From CCO to CEO – Susanne’s growth path and leadership style

16:05 Building the Dream Team – Diversity, healthy debate, and shared values

21:10 Board & Investor Alignment – Governance during leadership change

22:40 Redefining Roles – Henrik’s shift to partnerships & thought leadership

25:02 Stakeholder Communications – Keeping customers & partners in the loop

30:12 Founders’ Advice – Mentorship, self‑awareness, and planning ahead

36:47 Future Road‑map – Scaling tech, funding, and global impact

38:50 Lightning Round & Wrap‑up – Quick takes and final thoughts

Resource Mentioned:

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Thomas Kirkegaard Jensen, CEO of Amplify Therapeutics and a seasoned entrepreneur in the life science startup world, joins Søren for an in-depth conversation about building healthy company culture in high-pressure environments.

Drawing on over 15 years of experience—including his pivotal role at Orphazyme, where he contributed to the development and FDA approval of a groundbreaking rare disease treatment (now part of Zevra Therapeutics through acquisition)

The discussion explores how to foster trust-based, high-performance cultures, with a focus on psychological safety, clear communication, competence mapping, and managing the organizational challenges that come with growth. Thomas reflects on his leadership style, the importance of understanding personal strengths and blind spots, and the tools and systems he uses to shape team culture intentionally.

Thomas shares practical insights on when to begin deliberately cultivating culture, how Amplify Therapeutics approaches team dynamics, and the key lessons he’s learned from leading in both startup and scale-up phases.

The conversation also touches on milestones in team development and R&D, and Thomas’s vision for the company’s future.

This episode is especially relevant for startup leaders and life science professionals interested in entrepreneurship, innovation, and building strong, sustainable teams in complex, high-stakes environments.

Timestamp and Shownotes:

00:43 – Thomas’s Journey in Biotech

02:04 – Deep Dive into Amplify Therapeutics

06:53 – The Birth of Amplify Therapeutics

16:40 – Building a Healthy Startup Culture

34:23 – Specialization and Responsibility Shifts

35:33 – Leadership and Organizational Growth

38:05 – Competence Mapping and Skills Assessment

39:33 – Trust and Communication in Teams

45:22 – Balancing Fast Decisions with Thoughtfulness

52:28 – Reflections on Achievements and Culture

55:18 – Advice for First-Time CEOs

56:43 – Future Challenges and Opportunities

58:15 – Support and Career Opportunities

01:02:39 – The Reality of Working in Biotech

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

15 min teaser episode. Listen to the full episode in EP56 (Full).

Today we're diving into a biotech story that should be on every venture capitalist’s radar: Amplify Therapeutics. This is a company that’s shaking up drug development for neurodegenerative diseases—think ALS, Parkinson’s, frontotemporal dementia—not by throwing money at the problem, but by building smarter, faster, and more efficiently.

Founded by Thomas Kirkegaard Jensen—yes, the same scientific mind behind the legacy of Orphazyme—Amplify is zeroing in on lysosomal function and proteostasis, two mechanisms that hold huge promise across multiple disease areas. But here’s the kicker: they’re doing it lean. They’ve built a capital-efficient model, using validated targets and real-world biomarkers to reduce risk and speed up timelines.

This isn’t a moonshot—it’s a well-designed, data-driven platform with serious scalability. And with their first program heading into the clinic, Amplify is already primed for partnerships, licensing deals, and smart funding. Add a leadership team with deep regulatory experience and a proven track record of exits, and you’ve got a company that’s not just ready for the next phase—it’s ready to lead.

For VCs looking for high-impact biotech with serious upside, this is one worth watching. Stay tuned—Amplify is just getting started.

Timestamp and Shownotes:

00:00:41 – Thomas shares his entry into biotech via Orphazyme

00:02:00 – Thomas emphasizes the importance of trust-based and healthy team culture for high-performance in biotech environments.

00:02:09 – Thomas explains Amplify’s mission: to develop medicines for genetically defined neurodegenerative diseases by targeting lysosomal biology.

00:03:00 – Discussion on whether Amplify is a platform-based company or asset-driven. Thomas describes their diversified small-molecule approach grounded in deep lysosomal expertise.

00:04:00 – Thomas shares how he reacquired assets from Zevra after Orphazyme's dissolution and spun them into a new company, Amplify Therapeutics.

00:06:00 – Licensing + Foundation of Amplify

00:06:33 – Thomas outlines how he secured a startup grant from BioInnovation Institute (BII) in Copenhagen while finalizing the licensing deal.

00:07:51 – Early Team Building

00:08:33 – Thomas discusses balancing speed, flexibility, and internal know-how through selective in-house work.

00:09:41 – Thomas explains their hybrid approach: outsourcing standard assays, while keeping complex, specialized biology assays in-house for better agility and knowledge retention.

00:11:12 – Current Pipeline Overview Amplify’s portfolio includes three projects:

1. Lead program with multiple chemistries

2. Oxford University collaboration

3. Potential Danish Cancer Society program
   

00:12:14 – Amplify is preparing for a fundraising round to scale operations and advance pipeline development

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Søren welcomes Svend Petersen and Niels Bjerg Jensen, the pioneering co-founders of Mycoverse, to explore the entrepreneurial journey of building a life science startup that bridges cutting-edge biotechnology and sustainable agriculture.

Mycoverse is at the forefront of innovation, leveraging high-throughput screening technology to develop natural solutions for fungal disease control — tackling one of the most pressing challenges in global food security while ensuring environmental safety. But transforming a scientific breakthrough into a viable commercial venture is no small feat.

In this conversation, Svend and Niels share the origin story of Mycoverse, tracing their journey from identifying a critical gap in the market to securing exclusive technology licenses and assembling a team dedicated to reshaping the agricultural landscape. They discuss the defining moments that drove them to build this company, the biggest challenges they’ve faced—including regulatory hurdles, investor skepticism, and early-stage pivots — and the strategies they’ve used to navigate these complexities.

Svend and Niels reflect on the personal lessons learned throughout their entrepreneurial journey — the resilience, adaptability, and vision required to drive innovation in the life sciences sector. They’ll also share their outlook on the future of Mycoverse, from immediate priorities to long-term goals, and offer insights for aspiring founders navigating similar challenges in this space.

If you’re passionate about the intersection of science, entrepreneurship, and the future of sustainable agriculture, this episode is packed with valuable takeaways on what it really takes to turn groundbreaking research into a thriving startup.

Stay tuned for an inspiring and in-depth conversation with the minds behind Mycoverse, right here on Life Science Talent Talks.

Timestamps:

00:39 Introduction to Mycoverse and Its Founders

02:04 Mycoverse's Mission and Technology

03:51 The Entrepreneurial Journey

05:01 The Birth of Mycoverse

08:09 Challenges and Milestones

12:46 Business Model and Future Plans

17:06 Funding and Investor Relations

18:46 Market Opportunities and Unique Positioning

19:45 Biologicals Discovery Platform: High-Throughput Screening on Filamentous Fungi

20:09 Regulatory Approval and Market Strategy

21:09 Non-GMO and EU Market Considerations

22:14 Partnerships and Customer Dialogues

25:31 Investor Concerns and Speed to Market

29:45 Proud Moments and Team Dynamics

33:39 Future Plans and Challenges

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Nehar explores the development of a dynamic life science talent community. They are joined by Pia Petersen and Ulrik Gade, who share their expertise on agile methodologies, flow-based leadership, and organizational psychology.  

The discussion delves into their professional journeys, the founding of Agil Procesforbedring, and the challenges they have navigated. A key focus is how leadership and self-organization can foster innovation and efficiency within life science organizations. The conversation highlights the importance of transparency, trust, and continuous improvement in building engaged, high-performing teams. 

Throughout the episode, Pia and Ulrik offer practical insights and real-world examples of effective management practices applicable to both startups and large enterprises. The episode concludes with book recommendations and actionable advice for life science professionals looking to enhance leadership and organizational effectiveness.

Timestamps:

00:59 Introduction to Our Guest: Pia Petersen

02:06 Ulrik Gade Journey into Agile and Leadership

04:02 Founding Agil Procesforbedring

07:57 Challenges and Focus of the Company

09:55 Leadership and Self-Organization

17:37 Measuring the Value of Facilitation

21:14 Continuous Improvement and Action Learning

23:51 The Conscious Leader's Dilemma

24:35 Stop Starting, Start Finishing

28:19 The Importance of Transparency

30:53 Engagement and Strategy in the Workplace

33:44 Self-Organization and Task Management

35:24 Operational and Strategic Contexts

38:15 Challenges and Excitements in Leadership

43:03 Final Thoughts and Takeaways

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach